Umbrella Systematic Review of Chinese Medicine for Diabetic Nephropathy
China National Knowledge Infrastructure(CNKI),Wanfang Data,China Science and Technology Journal Database(VIP),PubMed and Embase are searched by computer,and 30 articles are included in the systematic review of the treatment of stage Ⅲ-Ⅳ diabetic kidney disease with traditional Chinese medicine from 2013 to 2023.The distribution characteristics of evidence through a combination of charts and graphs are dis-played,and the literature quality is evaluated using quality evaluation tool AMSTAR-2.The research results show that the number of publications is on the rise overall,of which Astragalus membranaceus and Poria cocos account for the vast majority of traditional Chinese medicine components in intervention measures.The overall quality of Meta analysis is relatively lower with some key items performing poorly.The Meta analyses of Chi-nese medicine for the treatment of stage Ⅲ-Ⅳ diabetic nephropathy has formed a certain sizeable evidence group,but there are some problems in the methodology quality of the literature.The requirements of subse-quent researches need to be improved according to corresponding review standards,and more representative outcome indicators need to be chosen.
diabetic kidney diseasetraditional Chinese medicineMeta analysismethodologyquality as-sessment
万方数据
维普
